Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: Effects on hyperprolactinemia

Pharmacopsychiatry

Volumn 38, Issue 1, 2005, Pages 17-19

  Nakajima, M ^a,b   Terao, Takeshi ^a   Iwata, N ^c   Nakamura, J ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Komine Etoh Hospital   (Japan)

^c UNIVERSITY OF EAST ASIA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BROMPERIDOL; CHLORPROMAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PROLACTIN; QUETIAPINE;

ADULT; ARTICLE; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MENTAL DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; HYPERPROLACTINEMIA; MIDDLE AGED; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 14044273578     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837766     Document Type: Article

References (10)

1. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatr 1997; 154: 1-63
2. Halbreich U, Kinon BJ, Gilmore JA, Kahn LS. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 2003; 28 (suppl 1): 3-67
3. Hamner MB, Arvanitis LA, Miller BG, Link CGG, Hong WW. Plasma prolactin in schizophrenia subjects treated with Seroquel™ (ICI204,636). Psychopharmacol Bull 1996; 32: 107-110
4. Keller R, Mongini F. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci 2002; 23: 233-235
5. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003; 28 (suppl 2): 55-68
6. Kropp S, Ziegenbein M, Grohmann R, Engel RR, Degner D. Galactorrhea due to psychotropic drugs. Pharmacopsychiatry 2004; 37 (suppl 1): 84-88
7. Kunwar AR, Megna JL. Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapine. Ann Pharmacother 2003; 37: 206-208
8. Notelovitz M, Ware MD, Buhi WC, Dougherty MC. Prolactin: effects of age, menopausal status, and exogenous hormones. Am J Obstet Gynecol 1982; 143: 225-227
9. 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatr 1999; 156: 876-884
10. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinemia in women: pathphysiology, severity and consequences: selective literature review. Br J Psychiatr 2003; 182: 199-204